Mostra el registre parcial de l'element

dc.contributor.authorTravé-Asensio, Sergi
dc.contributor.authorGómez, Oriol
dc.contributor.authorCarratalá, Jose Vicente
dc.contributor.authorRobles, Carla
dc.contributor.authorFàbregas, Francesc
dc.contributor.authorLópez-Cano, Adrià
dc.contributor.authorRodríguez Rodríguez, Xavier
dc.contributor.authorRatera, Imma
dc.contributor.authorArís, Anna
dc.contributor.authorGarcia-Fruitos, Elena
dc.contributor.otherProducció Animalca
dc.date.accessioned2026-01-29T20:02:54Z
dc.date.available2026-01-29T20:02:54Z
dc.date.issued2025-12-22
dc.identifier.issn1475-2859ca
dc.identifier.urihttp://hdl.handle.net/20.500.12327/5017
dc.description.abstractBackground The development of antimicrobial treatments as alternatives to antibiotics to combat antimicrobial-resistant (AMR) bacteria is a global priority. Antimicrobial peptides and proteins such as Host Defense Peptides (HDPs) and endolysins are one of the alternatives that are being explored. HDPs are small, cationic, and amphiphilic antimicrobial peptides derived from the innate immune system exhibiting a broad-spectrum antimicrobial activity. On the other hand, endolysins are enzymes produced by bacteriophages to hydrolyze the bacterial peptidoglycan layer, offering more specific antimicrobial activity than HDPs. While short peptides can be chemically synthesized, this approach presents several limitations, and recombinant production is also being used. Escherichia coli is the most used bacterial expression system for protein production. Alternative systems based on Generally Recognized as Safe (GRAS) microorganisms such as Lactic Acid Bacteria (LAB) have also been employed. However, so far, no comparative studies have evaluated the production and activity of antimicrobial proteins expressed in E. coli versus LAB and this study aims to address that gap. Results To evaluate potential differences in the production of antimicrobial proteins using E. coli and two LAB (Lactococcus lactis and Lactiplantibacillus plantarum) hosts, various proteins were evaluated. These included two HDPs fused to a GFP, two multidomain HDP-based proteins and one endolysin. The results revealed a clear influence of the expression system on the quality of HDP-based protein, including both GFP fusions and multidomain constructs. Protein yield was higher in E. coli and all HDP-based proteins exhibited higher antimicrobial activity when expressed in E. coli compared to L. lactis and L. plantarum. In contrast, endolysin activity was comparable when produced in E. coli and L. lactis. Conclusions These results demonstrate that the choice of bacterial expression host significantly affects not only the yield but, more importantly, the antimicrobial activity of HDP-based proteins. For these proteins, the antimicrobial activity was consistently higher when produced in E. coli. In contrast, endolysins exhibited similar characteristics regardless of whether they were expressed in E. coli or in L. lactis.ca
dc.description.sponsorshipThis work was financially supported by MICIU/AEI/ https://doi.org/10.13039/501100011033, grant number PID2022-136521OB-I00, PID2022-137332OB-I00 and CEX2023001263-S. ST-A. received a pre-doctoral fellowship from Ministerio de Universidades (Spain), and JVC was supported with a Margarita Salas grant for the training of young doctoral graduates (grant no. 722713). The authors are also grateful for the financial support received from Instituto de Salud Carlos III through and the Networking Research Center on Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN). The authors also acknowledge the ICTS NANBIOSIS for the support of the Biomaterial Processing and Nanostructuring Unit (U6) at ICMAB-CSIC (https://www.nanbiosis.es/portfolio/u6- biomaterialprocessing-and-nanostructuring-unit/) and the assistance of the ICMAB-CSIC Scientific & Technical Services: SOFT.ca
dc.format.extent11ca
dc.language.isoengca
dc.publisherSpringer Natureca
dc.relation.ispartofMicrobial Cell Factoriesca
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalca
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleRecombinant production of antimicrobial proteins in bacterial expression systems: Escherichia coli vs. lactic acid bacteriaca
dc.typeinfo:eu-repo/semantics/articleca
dc.description.versioninfo:eu-repo/semantics/publishedVersionca
dc.rights.accessLevelinfo:eu-repo/semantics/openAccess
dc.embargo.termscapca
dc.relation.projectIDMICINN/Programa Estatal para impulsar la investigación científico-técnica y su transferencia/PID2022-137332OB-I00/ES/NANOARQUITECTONICA PARA CREAR NUEVOS NANOMATERIALES MOLECULARES PARA APLICACIONES BIOMEDICAS/ca
dc.relation.projectIDMICINN/Programa Estatal para impulsar la investigación científico-técnica y su transferencia/CEX2023-001263-S/ES/ /ca
dc.subject.udc579ca
dc.identifier.doihttps://doi.org/10.1186/s12934-025-02904-9ca
dc.contributor.groupProducció de Remugantsca


Fitxers en aquest element

 

Aquest element apareix en la col·lecció o col·leccions següent(s)

Mostra el registre parcial de l'element

Attribution-NonCommercial-NoDerivatives 4.0 International
Excepte que s'indiqui una altra cosa, la llicència de l'ítem es descriu com http://creativecommons.org/licenses/by-nc-nd/4.0/
Comparteix a TwitterComparteix a LinkedinComparteix a FacebookComparteix a TelegramComparteix a WhatsappImprimeix